Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomas

Digestive Diseases and Sciences

Volumn 48, Issue 1, 2003, Pages 223-229

  Sheikh, Rafiq A ^a,d   Min, Byung Hee ^a   Yasmeen, Shagufta ^a   Teplitz, Raymond ^a   Tesluk, Henry ^a   Ruebner, Boris Henry ^a   Tobi, Martin ^b   Hatfield, James ^b   Fligiel, Suzanne ^b   Lawson, Michael J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d SAN JOAQUIN GENERAL HOSPITAL   (United States)

Author keywords

Adenoma; Colorectal neoplasms; Follow up studies; Ki 67; Monoclonal antibodies; Neoplasm invasiveness; P53 genes; p53 protein

Indexed keywords

DNA; KI 67 ANTIGEN; MOLECULAR MARKER; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ADNAB 9; PROTEIN P53; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; CANCER RISK; CLINICAL FEATURE; COLON ADENOMA; COLON POLYP; COLORECTAL CANCER; COLORECTAL TUMOR; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPLASIA; EARLY DIAGNOSIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; PLOIDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

ADENOMATOUS POLYPS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; COLORECTAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PLOIDIES; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037286088     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021727608133     Document Type: Article

References (27)

1. Atkin WS, Morson BC, Cuzick J: Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326(10):658-662, 1992
2. Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, Shike M, Weissfeld J, Burt R, Cooper MR, Kikendal JW, Cahill J: Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 342(16):1149-1155, 2000
3. Van Stolk RU, Beck GJ, Baron JA, Haile R, Summers R: Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. The Polyp Prevention Study Group. Gastroenterology 115(1):13-18, 1998
4. Levin TR, Palitz A, Grossman S, Conell C, Finkler L, Ackerson L, Rumore G, Selby JV: Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA 281(17):1611-1617, 1999
5. Wolley RC, Schreiber K, Koss LG, Karas M, Sherman A: DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Natl Cancer Inst 69(1):15-22, 1982
6. Kokal W, Sheibani K, Terz J, Harada JR: Tumor DNA content in the prognosis of colorectal carcinoma. JAMA 13;255(22):3123-3127, 1986
7. Armitage NC, Robins RA, Evans DF, Turner DR, Baldwin RW, Hardcastle JD: The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg 72(10):828-830, 1985
8. Tobi M, Maliakkal BJ, Zitron I, Alousi M, Goo R, Nochomovitz L, Luk G: Adenoma-derived antibody, Adnab-9 recognizes a membrane-bound glycoprotein in colonic tissue and effluent material from patients with colorectal neoplasia. Cancer Lett 30:67(1):61-69, 1992
9. Tobi M, Kaila V, Hassan N, Gallinger S, Fligiel S, Hatfield J, Gesell M, Sokr W, Luk G, Odze RD: Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestine. Hum Pathol 30(4):467-473, 1999
10. Tobi M, Darmon E, Phillips T, Heller T, Rozen P, Nochomovitz L, Steinberg W: Increased expression of a putative adenoma-associated antigen in precolonoscopic effluent of patients with colorectal cancer. Cancer Lett 15;51(1):21-25, 1990
11. Tobi M, Kaila V, Goo R, Kinzie J, Ehrinpreis M, Maliakkal BJ: An adenoma-associated antigen as a preneoplastic marker in familial polyposis coli versus sporadic colonic neoplasia. Gastroenterology 102:A403, (abstract) 1992
12. van den Berg FM, Tigges AJ, Schipper ME, den Hartog-Jager FC, Kroes WG, Walboomers JM: Expression of the nuclear oncogene p53 in colon tumors. J Pathol 157(3):193-199, 1989
13. Ahnen DJ, Feigl P, Quan G, Fenoglio-Preiser C, Lovato LC, Bunn PA Jr, Stemmerman G, Wells JD, Macdonald JS, Meyskens FL Jr: Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res 15;58(6):1149-1158, 1998
14. Wong AJ, Kohn GJ, Schwartz HJ, Ruebner BH, Lawson MJ: Colorectal cancer and noncancer patients have similar labeling indices by microscopy and computed image analysis. Hum Pathol 26(12):1329-1332, 1995
15. Lawson MJ, White LM, Coyle P, Bulter RN, Roberts-Thomson IC, Conyers RA: An assessment of proliferative and enzyme activity in transitional mucosa adjacent to colonic cancer. Cancer 64(5):1061-1066, 1989
16. Kim EC, Lance P: Colorectal polyps and their relationship to cancer. Gastroenterol Clin North Am 26(1):1-17, 1997
17. Cooper HS: Surgical pathology of endoscopically removed malignant polyps of the colon and rectum. Am J Surg Pathol 7(7):613-623, 1983
18. Wolff WI, Shinya H: Definitive treatment of "malignant" polyps of the colon. Ann Surg 182(4):516-525, 1975
19. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29(4):577-580, 1981
20. Teplitz RL, Joyce JE, Doroshov SI, Min BH: A preliminary ploidy analysis of diploid and triploid salmonids. Can J Fish Aquat Sci 51 (suppl 1):38-41, 1994
21. Lotfi AM, Spencer RJ, Ilstrup DM, Melton LJ 3d: Colorectal polyps and the risk of subsequent carcinoma. Mayo Clin Proc 61(5):337-343, 1986
22. O'Brien MJ, Winawer SJ, Zauber AG, Gottlieb LS, Sternberg SS, Diaz B, Dickersin GR, Ewing S, Geller S, Kasimian D: The National Polyp Study: patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 98(2):371-379, 1990
23. Shinya H, Wolff WI: Morphology, anatomic distribution and cancer potential of colonic polyps. Ann Surg 190(6):679-683, 1979
24. Hixson LJ, Fennerty MB, Sampliner RE, McGee D, Garewal H: Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst 82(22):1769-1772, 1990
25. Neugut AI, Jacobson JS, Ahsan H, Santos J, Garbowski GC, Forde KA, Treat MR, Waye J: Incidence and recurrence rates of colorectal adenomas: a prospective study. Gastroenterology 108(2):402-408, 1995
26. Griffioen G, Cornelisse CJ, Verspaget HW, Sier CF, Eulderink F, Bosman FT, Lamers CB: Association of aneuploidy in index adenomas with metachronous colorectal adenoma development and a comparison. Cancer 70(8):2035-2043, 1992
27. Saleh HA, Aburashed A, Bober P, Tabaczka P: P53 protein immunohistochemical expression in colonic adenomas with and without associated carcinoma. Am J Gastroenterol 93(6):980-984, 1998